SCHEMBL3312957

SCHEMBL3312957

CCCCn1cc[n+](CC)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.57
CA2 P00918 8/20 0.57
KMT2A Q03164 3/20 0.56
EEF2K O00418 2/20 0.56
EEF2 P13639 2/20 0.56
MEN1 O00255 2/20 0.56
PLK4 O00444 1/20 0.56
JAK2 O60674 1/20 0.56
EGFR P00533 1/20 0.56
TYK2 P29597 1/20 0.56
FLT3 P36888 1/20 0.56
BLM P54132 1/20 0.56
ITK Q08881 1/20 0.56
PIM2 Q9P1W9 1/20 0.56
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 2/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
LMNA P02545 1/20 0.34
TYR P14679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30980166 0.98 CA1 (0.55) CA1CA2KMT2AEEF2KEEF2
SCHEMBL3313833 0.94 KMT2A (0.63) CA1CA2KMT2AEEF2KEEF2
SCHEMBL3309543 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5287729 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5306601 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5289166 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5283716 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5304754 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5287856 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2
SCHEMBL5288796 0.93 KMT2A (0.66) CA1CA2KMT2AEEF2KEEF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652157-A1 PROCESS FOR TREATING IMINIUM SALT-BASED IONIC LIQUIDS Technikum Laubholz GmbH (DE) 2025-11-26 EP claimed
WO-2024153790-A1 PROCESS FOR TREATING IMINIUM SALT-BASED IONIC LIQUIDS TECHNIKUM LAUBHOLZ GMBH (DE) 2024-07-25 WO claimed
US-20230378459-A1 SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-11-23 US disclosed
US-20230327207-A1 Storage Battery, Battery Control Unit, and Electronic Device SEMICONDUCTOR ENERGY LAB (JP) 2023-10-12 US disclosed
US-20230231199-A1 SECONDARY BATTERY AND VEHICLE INCLUDING SECONDARY BATTERY SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-07-20 US disclosed
US-20200280101-A1 STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2020-09-03 US disclosed
US-10658701-B2 Storage battery, battery control unit, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-05-19 US disclosed
US-20170237127-A1 ELECTRODE, MANUFACTURING METHOD THEREOF, NEGATIVE ELECTRODE, MANUFACTURING METHOD THEREOF, POWER STORAGE DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-17 US disclosed
US-20170222265-A1 STORAGE BATTERY, BATTERY CONTROL UNIT, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-03 US disclosed
EP-2958181-B1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2017-06-14 EP disclosed
US-9653754-B2 Nonaqueous electrolytes and nonaqueous-electrolyte secondary batteries employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2017-05-16 US disclosed
EP-2166611-B1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE MITSUBISHI CHEM CORP (JP) 2013-12-25 EP disclosed
US-20130280622-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2013-10-24 US disclosed
EP-2535976-A1 NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2012-12-19 EP disclosed
US-20120308881-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQEUOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-12-06 US disclosed
US-20120264010-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2012-10-18 US disclosed
US-20100099031-A1 NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2010-04-22 US disclosed
EP-2166611-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2010-03-24 EP disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230378459-A1 SECONDARY BATTERY, ELECTRONIC DEVICE, AND VEHICLE VDAC3, VDAC2, SCO2 CA1 136/4885CA2 54/4885KMT2A 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.